1. Home
  2. SCLX vs SRL Comparison

SCLX vs SRL Comparison

Compare SCLX & SRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$9.03

Market Cap

90.0M

Sector

Health Care

ML Signal

HOLD

Logo Scully Royalty Ltd.

SRL

Scully Royalty Ltd.

HOLD

Current Price

$8.94

Market Cap

83.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCLX
SRL
Founded
2011
2017
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
90.0M
83.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SCLX
SRL
Price
$9.03
$8.94
Analyst Decision
Hold
Analyst Count
1
0
Target Price
N/A
N/A
AVG Volume (30 Days)
80.8K
40.6K
Earning Date
11-14-2025
04-24-2026
Dividend Yield
N/A
11.48%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$40,360,000.00
$26,224,099.00
Revenue This Year
N/A
N/A
Revenue Next Year
$749.70
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.60
$5.13
52 Week High
$34.27
$9.64

Technical Indicators

Market Signals
Indicator
SCLX
SRL
Relative Strength Index (RSI) 34.71 56.73
Support Level $7.82 $8.68
Resistance Level $10.41 $9.15
Average True Range (ATR) 1.02 0.35
MACD 0.05 -0.08
Stochastic Oscillator 20.56 20.56

Price Performance

Historical Comparison
SCLX
SRL

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About SRL Scully Royalty Ltd.

Scully Royalty Ltd is a royalty-based company that maximizes earnings upon its iron ore royalty interest. The company's business segments include Royalty, which includes an interest in an iron ore mine; Industrial, which includes projects in resources and services; Merchant Banking, which comprises regulated merchant banking activities; and others. The majority of the revenue is generated from the Royalty segment. The company's geographical segments include Canada, Africa, America, Asia, and Europe, out of which Canada accounts for the majority of the revenue.

Share on Social Networks: